Original news and analysis on international IP policy
Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines.
With the end of the annual World Health Assembly looming tomorrow, member states are working away behind closed doors to finalise a resolution on how the World Health Organization shall work with outside actors going forward.
According to a new report, by 2050, some 10 million lives could be lost a year due to antimicrobial resistance. This is an issue which has been central to this year’s World Health Assembly, and is of global consequence. Delegates gathered for the occasion noted a report by the World Health Organization secretariat on the global action plan on antimicrobial resistance adopted last year and options to develop a global stewardship framework to try to limit the use of antibiotics and develop new ones.
A side event to the World Health Assembly organised by a number of delegations on antibiotic research and innovation reflected the deep global concern about antimicrobial resistance and the lack of candidates to replace what was once considered as a miracle of modern medicine.
Adopted five years ago, the World Health Organization Pandemic Influenza Preparedness (PIP) Framework is currently undergoing its first review. Member states gathered in committee at the World Health Assembly yesterday mostly expressed support for the framework, and took note of a report by the WHO secretariat.
At a side event to this week's World Health Assembly, GlaxoSmithKline detailed measures taken by the company to dispel the perception of conflict of interest, and build trust, including amending the ways its sales forces operate, and no longer paying speakers at scientific congresses, and said it wants to provide leadership on the issue. Patients and physicians associations call for mainstreaming those practices.
At a side event to this week’s annual World Health Assembly, a member of the Netherlands Ministry of Health delivered an unexpected speech on access to medicines, calling for more clarity in the setting of medicine prices, looking inside and outside of the patent system for solutions, and praising de-linkage. Other panellists viewed partnerships as a key ingredient to fill research and development gaps. And a representative from the Gates Foundation advised against a hasty switch to new system.
This week, country delegates meeting at the annual World Health Assembly are expected to come to an agreement on a framework managing the UN World Health Organization’s relationship with outside actors, such as the private sector, philanthropic organisations and civil society groups.
A new initiative seeking to develop new antibiotic treatments is being launched today at the annual World Health Assembly. The Global Antibiotic Research and Development (GARD) is a partnership between the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi).
The fight against epidemics cannot only rely on innovation, according to speakers at an event organised by the pharmaceutical industry alongside the annual World Health Assembly’s opening day. Strong health systems, collaboration of all stakeholders, preventive measures, and the ability to fund research are prerequisite to innovation, they said.